Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Woodruff, D. Hill, P. Boden, R. Pinnock, L. Singh, J. Hughes (1991)
Functional role of brain CCK receptorsNeuropeptides, 19
Susan Mesquita, M. Beinfeld, J. Crawley (1990)
Microdialysis as an approach to quantitate the release of neuropeptidesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 14
G. Paxinos, C. Watson (1986)
The Rat Brain in Stereotaxic Coordinates
P. Emson, C. Lee, J. Rehfeld (1980)
Cholecystokinin octapeptide: vesicular localization and calcium dependent release from rat brain in vitro.Life sciences, 26 25
(1981)
Separate populations of cholecystokinin and 5-HT containing cells in the dorsal raphe and their contribution to its ascending projections
A. Imperato, G. Chiara (1984)
Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites, 4
J. Vanderhaeghen, J. Signeau, W. Gepts (1975)
New peptide in the vertebrate CNS reacting with antigastrin antibodiesNature, 257
S. Butcher, A. Varró, J. Kelly, G. Dockray (1989)
In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletionBrain Research, 505
T. Ho¨kfelt, T. Ho¨kfelt, L. Skirboll, J. Rehfeld, J. Rehfeld, M. Goldstein, M. Goldstein, K. Markey, K. Markey, O. Dann, O. Dann (1980)
A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracingNeuroscience, 5
L. Swanson (1984)
The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5Trends in Neurosciences, 7
T. Bártfai, K. Iverfeldt, G. Fisone, P. Serfozo (1988)
Regulation of the release of coexisting neurotransmitters.Annual review of pharmacology and toxicology, 28
Harvey McMahon, David Nicholls (1991)
The bioenergetics of neurotransmitter release.Biochimica et biophysica acta, 1059 3
M. Pinget, E. Straus, R. Yalow (1979)
Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex.Life sciences, 25 4
J. Rehfeld (1985)
Neuronal Cholecystokinin: One or Multiple Transmitters?Journal of Neurochemistry, 44
M. Raiteri, G. Fontana, E. Fedele (1990)
Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus.European journal of pharmacology, 184 2-3
(1990)
Pathways to regulated exocytosis
( I 990 ) Development of a class of cholecystokinin type B receptor antagonists having potent anxiolytic activity
P. Paudice, M. Raiteri (1991)
Cholecystokinin release mediated by 5‐HT3 receptors in rat cerebral cortex and nucleus accumbensBritish Journal of Pharmacology, 103
M. Takita, T. Tsuruta, Y. Oh-hashi, Takeshi Kato (1989)
In vivo release of cholecystokinin-like immunoreactivity in rat frontal cortex under freely moving conditionsNeuroscience Letters, 100
J. Rehfeld (1978)
Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin.The Journal of biological chemistry, 253 11
M. Blaustein, J. Goldring (1975)
Membrane potentials in pinched‐off presynaptic nerve ternimals monitored with a fluorescent probe: evidence that synaptosomes have potassium diffusion potentials.The Journal of Physiology, 247
( 1 99 1 ) Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain : micro - dialysis combined with a sequential multiple antigen radioim - munoassay
S. Hendry, E. Jones, J. DeFelipe, D. Schmechel, C. Brandon, P. Emson (1984)
Neuropeptide-containing neurons of the cerebral cortex are also GABAergic.Proceedings of the National Academy of Sciences of the United States of America, 81 20
N. Maidment, B. Siddall, V. Rudolph, E. Erdelyi, C. Evans (1991)
Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassayNeuroscience, 45
D. Kooy, S. Hunt, H. Steinbusch, A. Verhofstad (1981)
Separate populations of cholecystokinin and 5-hydroxytryptamine-containing neuronal cells in the rat dorsal raphe, and their contribution to the ascending raphe projectionsNeuroscience Letters, 26
J. Crawley (1991)
Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 12
P. Camilli, R. Jahn (1990)
Pathways to regulated exocytosis in neurons.Annual review of physiology, 52
P. Somogyi, A. Hodgson, A. Smith, M. Nunzi, A. Gorio, J. Wu (1984)
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material, 4
B. Jones, B. Costall, A. Domeney, M. Kelly, R. Naylor, N. Oakley, M. Tyers (1988)
The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonistBritish Journal of Pharmacology, 93
H. Benveniste, P. Hüttemeier (1990)
Microdialysis—Theory and applicationProgress in Neurobiology, 35
R. Innis, S. Snyder (1980)
Distinct cholecystokinin receptors in brain and pancreas.Proceedings of the National Academy of Sciences of the United States of America, 77 11
(1993)
Inhibition by 5 - HT 3 receptor antagonists of cholecystokinin release from the frontal cortex of freely moving rats
L. Larsson, J. Rehfeld (1979)
Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous systemBrain Research, 165
(1989)
Protection by serine
Boer (1992)
The effect of intrastriatal application of directly and indirect y acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysisNaunyn Schmiedebergs Arch. Pharmacol, 345
C. Rose, A. Camus, J. Schwartz (1989)
Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slicesNeuroscience, 29
( I 99 1 ) Cholecystokinin - dopamine interactions
John Hughes, P. Boden, Brenda Costall, A. Domeney, E. Kelly, D. Horwell, J. Hunter, R. Pinnock, Geoffrey Woodruff (1990)
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.Proceedings of the National Academy of Sciences of the United States of America, 87 17
M. Verhage, W. Ghijsen, D. Nicholls, V. Wiegant (1991)
Characterization of the Release of Cholecystokinin‐8 from Isolated Nerve Terminals and Comparison with Exocytosis of Classical TransmittersJournal of Neurochemistry, 56
Abstract: The release of cholecystokinin‐like immunoreactivity (CCK‐LI) from the frontal cortex of freely moving rats has been studied using a transcerebral microdialysis technique coupled to a radioimmunoassay procedure. Basal levels of CCK‐LI in the dialysate were above detection limits (2.4 ± 0.7 pg/20 min; n = 8). High‐K+ media evoked CCK‐LI overflow in a concentration‐dependent manner. The threshold concentration was 50 mM KCI. The peak overflow evoked by 100 mM K+ amounted to 42.7 ± 2.8 pg/20 min (n = 6); it was totally Ca2+ dependent but insensitive to 1 μM tetrodotoxin. Infusion of 4‐aminopyridine (1 mM; 20 min) evoked an overflow of CCK‐LI (32 ± 2.3 pg/ 20 min; n = 4), wnich was totally Ca2+ dependent and tetrodotoxin sensitive. Depolarization with 100 μg/ml of veratrine (20 min) provoked a CCK‐LI overflow (62.2 ± 10 pg/20 min; n = 6), which was also blocked by tetrodotoxin or by the absence of Ca2+ ions. The CCK‐LI material collected under basal conditions or during veratrine infusion consisted essentially of CCK octapeptide sulfate. The veratrine‐induced CCK‐LI overflow did not change significantly when the infusion time was prolonged to 100 min. A second 20‐min stimulus with 100 μg/ml of veratrine applied 200 min after a first 20‐min stimulus evoked a barely significant CCK‐LI overflow. These data suggest that one single 20‐min stimulus with 100 μg/ml of veratrine may be sufficient to deplete the CCK‐LI releasable stores and that >200 min are required to replenish the depleted CCK‐containing vesicles. Taken together the data allow us to conclude that the physiology and the pharmacology of CCK release can be adequately studied in vivo by brain microdialysis.
Journal of Neurochemistry – Wiley
Published: Jan 1, 1993
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.